Asialoganglioside GM1 IgA

Measures IgG and IgA antibodies against different tissue antigens that are found from head to toe. These tissues are involved in more than 90 different autoimmune diseases. Detection of antibodies against these antigens at the early stage helps in the prevention and management of many autoimmune disorders since these predictive antibodies can be detected 3-19 years before the development of the clinical stage of an autoimmune disease. Developed and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2008, 2020, 2021, 2023, and 2024.

Measures IgG, IgA, and IgM antibodies against five major neuron-specific antigens: myelin basic protein, asialoganglioside, alpha + beta tubulin, cerebellar, and synapsin. These antibodies are detected in patients with a variety of neuroimmune disorders, chronic fatigue/fibromyalgia, viral infections including SARS-CoV-2, EBV, CMV, HHV-6, long COVID, autism, ADD/ADHD, neuropsychiatric disorders, and exposure to toxic chemicals and molds and mycotoxins. Developed, patented, and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2005, 2007, 2008, 2020, and 2023.

Measures IgG and IgA antibodies against different tissue antigens that are found from head to toe. These tissues are involved in more than 90 different autoimmune diseases. Detection of antibodies against these antigens at the early stage helps in the prevention and management of many autoimmune disorders since these predictive antibodies can be detected 3-19 years before the development of the clinical stage of an autoimmune disease. Developed and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2008, 2020, 2021, 2023, and 2024.